Amide surrogates of matrix metalloproteinase inhibitors: Urea and sulfonamide mimics
- 23 September 1997
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 7 (18) , 2331-2336
- https://doi.org/10.1016/s0960-894x(97)00182-0
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- X-ray structure of a hydroxamate inhibitor complex of stromelysin catalytic domain and its comparison with members of the zinc metalloproteinase superfamilyStructure, 1996
- Section Review Biologicals & Immunologicals: Matrix metalloproteinases and malignant disease: Recent developmentsExpert Opinion on Investigational Drugs, 1996
- Recent advances in matrix metalloproteinase inhibitor researchDrug Discovery Today, 1996
- Chapter 24. Inhibition of Matrix Metalloproteinases.Published by Elsevier ,1996
- Review Oncologic, Endocrine & Metabolic: Recent developments in matrix metalloproteinase inhibitorsExpert Opinion on Therapeutic Patents, 1995
- Synthesis of Peptidosulfinamides and Peptidosulfonamides: Peptidomimetics Containing the Sulfinamide or Sulfonamide Transition-State IsostereThe Journal of Organic Chemistry, 1995
- Inhibition of Matrix Metalloproteinases by Hydroxamates Containing Heteroatom-Based Modifications of the P1' GroupJournal of Medicinal Chemistry, 1995
- Metalloproteinase super–families and drug designNature Structural & Molecular Biology, 1994
- The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseasesTrends in Biotechnology, 1992
- A novel coumarin‐labelled peptide for sensitive continuous assays of the matrix metalloproteinasesFEBS Letters, 1992